Philippe Menu insider trades: SOPHiA GENETICS (SOPH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Philippe reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $7.26 | $36K | Direct | Oct 14, 2026 (2d) |
| Oct 5, 2026 | SOPH | ↓ Sell10b5-1 | 7,394 | $8.13 | $60K | Direct | Oct 7, 2026 (2d) |
| Sep 14, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $7.88 | $39K | Direct | Sep 16, 2026 (2d) |
| Aug 25, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $8.68 | $43K | Direct | Aug 26, 2026 (1d) |
| Aug 12, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $7.52 | $38K | Direct | Aug 14, 2026 (2d) |
| Jul 13, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $5.70 | $29K | Direct | Jul 14, 2026 (1d) |
| Jul 6, 2026 | SOPH | ↓ Sell10b5-1 | 7,393 | $5.16 | $38K | Direct | Jul 7, 2026 (1d) |
| Jun 12, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $4.95 | $25K | Direct | Jun 15, 2026 (3d) |
| May 26, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $4.95 | $25K | Direct | Jun 1, 2026 (6d) |
| May 19, 2026 | SOPH | ↓ Sell10b5-1 | 608 | $4.61 | $3K | Direct | May 20, 2026 (1d) |
| May 12, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $4.67 | $23K | Direct | May 13, 2026 (1d) |
| Apr 27, 2026 | SOPH | ↓ Sell10b5-1 | 5,000 | $4.82 | $24K | Direct | Apr 28, 2026 (1d) |
| Apr 14, 2026 | SOPH | ↓ Sell10b5-1 | 1,600 | $4.96 | $8K | Direct | Apr 16, 2026 (2d) |
| Apr 13, 2026 | SOPH | ↓ Sell10b5-1 | 8,125 | $4.73 | $38K | Direct | Apr 14, 2026 (1d) |
| Apr 9, 2026 | SOPH | ↓ Sell10b5-1 | 4,731 | $4.80 | $23K | Direct | Apr 10, 2026 (1d) |
| Apr 7, 2026 | SOPH | ↓ Sell10b5-1 | 5,100 | $4.86 | $25K | Direct | Apr 8, 2026 (1d) |
| Mar 19, 2026 | SOPH | ↓ Sell10b5-1 | 608 | $4.79 | $3K | Direct | Mar 20, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SOPH insiders
Open-market trades in the last 12 months
About Philippe Menu's insider trades
Philippe Menu is Chief Medical Officer at SOPHiA GENETICS (SOPH). Since Mar 19, 2026, Philippe has reported no open-market purchases and 17 sales worth $480K on SEC Form 4. In the last 12 months: 17 sales ($480K).
17 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SOPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.